Trexquant Investment LP

Position in BHVN — Biohaven Ltd.

CIK 1633445 STAMFORD, CT

Position in BHVN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$7,494,966

+$68,998 QoQ

Shares Held

503,694

-42.6% QoQ

Ownership

0.333%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#47

of 294 holders

Holding Since

Mar 2023

11 quarters on record

Voting authority Sole 91% Shared 0% None 9%

Healthcare · as of Jun 30, 2026

Trexquant Investment LP holds $587,455,425 across 144 Biotechnology names. BHVN ranks #19 (1.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRNA	Moderna, Inc.	505,160	$35,376,354
2	REGN	Regeneron Pharmaceuticals, Inc.	41,839	$26,088,290
3	RVMD	Revolution Medicines, Inc.	120,122	$22,496,448
4	AXSM	Axsome Therapeutics, Inc.	83,679	$20,482,108
5	RARE	Ultragenyx Pharmaceutical Inc.	556,385	$18,577,695
6	INSM	INSMED Inc	156,553	$16,691,680
7	SRRK	Scholar Rock Holding Corp	275,712	$15,164,160
8	EXEL	Exelixis, Inc.	275,209	$14,974,121

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$7,494,966	503,694	-42.6%	Shares	Sole	2026-08-14
2026-03-31	$7,425,968	877,774	+45.3%	Shares	Sole	2026-05-15
2025-12-31	$6,821,214	604,182	+202.3%	Shares	Sole	2026-02-17
2025-09-30	$2,999,763	199,851	+91.6%	Shares	Sole	2025-11-14
2025-06-30	$1,471,503	104,288	+849.8%	Shares	Sole	2025-08-12
2024-12-31	$410,103	10,980	-41.5%	Shares	Sole	2025-02-12
2024-09-30	$938,036	18,772	-10.9%	Shares	Sole	2024-11-12
2024-03-31	$1,152,591	21,075	-10.0%	Shares	Sole	2024-05-14
2023-09-30	$608,842	23,408	-35.4%	Shares	Sole	2023-11-13
2023-06-30	$867,195	36,254	+148.9%	Shares	Sole	2023-08-11
2023-03-31	$198,957	14,565	—	Shares	Sole	2023-05-15
No filing history on record for this holder in this stock.